Specimen Validity Testing Market

1
MarketsandMarkets Presents

• Specimen Validity Testing Market
•  - Global Forecasts to 2023

2

• The global specimen validity testing market is
  projected to reach USD 1.49 Billion by 2023 from
  USD 1.10 Billion in 2018, at a CAGR of 6.3. The
  growth of the specimen validity testing market is
  primarily driven by the growth in drug screening
  market and increase in workplace drug testing.
• The report segments the global specimen validity
  testing market by product and service, type, end
  user, and region.
• The specimen validity testing market is broadly
  segmented into products and services. The
  services segment is expected to register the
  highest growth rate during the forecast period.
  The high growth in this segment is attributed to
  the implementation of workplace drug testing in
  several countries, increase in the number of drug
  screening tests, and growing number of drug
  screening laboratories across the globe.

3
https//www.marketsandmarkets.com/Market-Repo
rts/specimen-validity-testing-market-147024121.htm
l Based on product, the specimen validity
testing market is categorized into reagents,
calibrators, controls assay kits and
disposables. In 2018, the reagents, calibrators,
and controls segment is expected to account for
the largest share of the market, owing to the
repeated purchase of these products.
4

• The global specimen validity testing market by
  type is segmented into laboratory testing and
  rapid/POC testing. In 2018, the laboratory
  testing segment is expected to account for the
  largest share of the market. However, the
  rapid/POC testing segment is expected to register
  the highest growth during the forecast period.
  The high growth of the rapid/POC testing segment
  can be attributed benefits such as instant
  results, ability to detect multiple drugs at
  once, and the recurrent repetitive usage of
  rapid/POC drug testing products.
• Based on end user, the specimen validity testing
  market is segmented into workplaces, drug
  screening laboratories, criminal justice and law
  enforcement agencies, pain management centers,
  drug rehabilitation centers, and other end users.
  In 2018, the workplaces segment is expected to
  account for the largest share of the market. The
  growth in this segment can be attributed to the
  increasing incidence of substance abuse in the
  workplace and the growing number of organizations
  that have made regular drug screening mandatory.

5
Contact Us

• Mr. RohanMarkets and Markets UNIT no 802, Tower
  no. 7, SEZMagarpatta city, HadapsarPune,
  Maharashtra 411013, India1-888-600-6441Email
  sales_at_marketsandmarkets.com
• MarketsandMarkets Blog
• http//www.linkedin.com/company/marketsandmarkets
• http//twitter.com/marketsmarkets

6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.